COMPASS THERAPEUTICS, INC. (CMPX) Operating cash flow 2018–2025
COMPASS THERAPEUTICS, INC. (CMPX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.1MFY2025 · since FY2018: -$32,759 → -$49.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.1M | -9.6% |
| FY2024 | -$44.9M | -10.4% |
| FY2023 | -$40.6M | -19.0% |
| FY2022 | -$34.1M | -73.5% |
| FY2021 | -$19.7M | +26.6% |
| FY2020 | -$26.8M | -83382.8% |
| FY2019 | -$32,106 | +2.0% |
| FY2018 | -$32,759 | — |
Source: SEC XBRL filings · For reference only · Not investment advice